UBE3A activates the NOTCH pathway and promotes esophageal cancer progression by degradation of ZNF185
TLDR
The role of UBE3A and ZNF185 in esophageal cancer growth was assessed by MTS assays, colony formation assays and experiments in mouse xenograft models as discussed by the authors.Abstract:
Background: Esophageal cancer is the sixth-most common fatal malignant tumor worldwide. Little is known regarding the genetic drivers that influence targeted therapy outcomes in patients with esophageal cancer. Exploring the pathogenesis of this lethal tumor could provide clues for developing appropriate therapeutic drugs. Ubiquitin-protein ligase E3A (UBE3A) reportedly promotes or suppresses various types of malignant tumors. However, the cancer-related role of UBE3A in esophageal cancer remains unclear. Methods: The relationship of UBE3A with the clinicopathological features of pancreatic tumors was bioinformatically investigated in the TCGA dataset. The protein levels of UBE3A and ZNF185 were assessed by Western blot and immunohistochemistry. The role of UBE3A and ZNF185 in esophageal cancer growth was assessed by MTS assays, colony formation assays, and experiments in mouse xenograft models. The interaction between UBE3A and ZNF185 was investigated by co-immunoprecipitation. The relationship between UBE3A, ZNF185, and NOTCH signaling pathway was explored by Western blot and quantitative real-time PCR. Results: We found that UBE3A was upregulated in patients with esophageal cancer and enhanced the cellular progression of esophageal cancer. Moreover, we found that UBE3A degraded ZNF185 in esophageal cancer. Additionally, ZNF185 suppressed the progression of esophageal cancer by inactivating the NOTCH pathway. Conclusions: These data demonstrated that aberrant expression of UBE3A led to enhanced progression of esophageal cancer through the ZNF185/NOTCH signaling axis. Therefore, UBE3A might be an ideal therapeutic candidate for esophageal cancer.read more
Citations
More filters
Journal ArticleDOI
RHBDL2 promotes the proliferation, migration, and invasion of pancreatic cancer by stabilizing the N1ICD via the OTUD7B and activating the Notch signaling pathway
TL;DR: In this article , the authors found that RHBDL2 is highly expressed in human PC cells and tissues and is significantly associated with distant metastasis and poor survival of patients with PC. But the correlation between RHBDl2 and PC remains unclear, therefore, there is an urgent need to explore new therapeutic strategies for PC treatment.
Journal ArticleDOI
Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer
TL;DR: In this article , the authors discuss how immune cell types of TME are correlated with immunotherapy in lung cancer and describe the efficacy of immunotherapy for driven gene mutations in Lung cancer, including KRAS, TP53, EGFR, ALK, ROS1, KEAP1, ZFHX3, PTCH1, PAK7, UBE3A, TNF-α, NOTCH, LRP1B, FBXW7, and STK11.
Journal ArticleDOI
MicroRNA-375 restrains the progression of lung squamous cell carcinoma by modulating the ERK pathway via UBE3A-mediated DUSP1 degradation
Junqing Gan,Yu Zhang,Shan-Lu Liu,Guannan Mu,Juan Zhao,Wei Jiang,Jiade Li,Qi Li,Yang Wu,Xinling Wang,Dehai Che,Xiao-mian Li,Xiaoyi Huang,Qingwei Meng +13 more
TL;DR: In this paper , the miR-375/UBE3A/DUSP1/ERK axis was investigated in lung squamous cell carcinoma (LUSC) and the effect of miR375 on tumorigenesis and metastasis.
References
More filters
Journal ArticleDOI
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.
TL;DR: GEPIA (Gene Expression Profiling Interactive Analysis) fills in the gap between cancer genomics big data and the delivery of integrated information to end users, thus helping unleash the value of the current data resources.
Journal ArticleDOI
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
TL;DR: It is demonstrated that the E6 proteins of the oncogenic HPVs that bind p53 stimulate the degradation of p53, which results in selective degradation of cellular proteins such as p53 with negative regulatory functions provides a novel mechanism of action for dominant-acting oncoproteins.
Journal ArticleDOI
The Notch signaling pathway: transcriptional regulation at Notch target genes.
Tilman Borggrefe,Franz Oswald +1 more
TL;DR: Notch signaling is reviewed with a focus on gene regulatory events at Notch target genes, of utmost importance to understand Notch signaling since certain RBP-J associated cofactors and particular epigenetic marks determine the specificity of notch target gene expression in different cell types.
Journal ArticleDOI
The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily
Zafar Nawaz,David M. Lonard,Carolyn L. Smith,Efrat Lev-Lehman,Sophia Y. Tsai,Ming-Jer Tsai,Bert W. O'Malley +6 more
TL;DR: It is found that the E6-associated protein (E6-AP/UBE3A) directly interacts with and coactivates the transcriptional activity of the human progesterone receptor (PR) in a hormone-dependent manner, suggesting that the AS phenotype results from a defect in the ubiquitin-proteosome protein degradation pathway.
Journal ArticleDOI
Notch signaling regulates mammary stem cell function and luminal cell-fate commitment.
Toula Bouras,Bhupinder Pal,François Vaillant,Gwyndolen Harburg,Marie Liesse Asselin-Labat,Samantha R. Oakes,Geoffrey J. Lindeman,Geoffrey J. Lindeman,Jane E. Visvader +8 more
TL;DR: It is shown that knockdown of the canonical Notch effector Cbf-1 in the MaSC-enriched population results in increased stem cell activity in vivo as well as the formation of aberrant end buds, implying a role for endogenous Notch signaling in restricting MaSC expansion.